6 episodes

This case-based online mentor workshop podcast focuses on practical strategies to manage metastatic breast cancer in your patients with triple negative disease. Presented by Lyndsay N. Harris, MD, it includes prerecorded Q & A from the proceedings of live audioconferences. This workshop podcast is a sequel to the data-driven webcast, "��Targeting the Treatment of Metastatic Breast Cancer" and is a course in the Mentor Workshops: Practice-Based Strategies for Managing Metastatic Breast Cancer Patients curriculum program.

Practice-Based Strategies: Triple Negative Breast Cancer Case Projects In Knowledge, Inc

    • Science

This case-based online mentor workshop podcast focuses on practical strategies to manage metastatic breast cancer in your patients with triple negative disease. Presented by Lyndsay N. Harris, MD, it includes prerecorded Q & A from the proceedings of live audioconferences. This workshop podcast is a sequel to the data-driven webcast, "��Targeting the Treatment of Metastatic Breast Cancer" and is a course in the Mentor Workshops: Practice-Based Strategies for Managing Metastatic Breast Cancer Patients curriculum program.

    Part 6. Q & A - Part 2/Case Conclusion

    Part 6. Q & A - Part 2/Case Conclusion

    Dr. Harris answers additional questions from the live audience on topics such as the role of erlotinib in triple-negative BC and the MOA of PARP inhibitors, and concludes the podcast with take-away messages regarding triple-negative BC.

    • 7 min
    Part 5. Q & A - Part 1

    Part 5. Q & A - Part 1

    Dr. Harris answers questions from the live audience on topics such as the role of biopsy, selecting 2nd- and 3rd-line regimens, the role of vitamin D, and the use of platinums in triple-negative BC.

    • 8 min
    Part 4. Role of Published Guidelines and Literature in Treatment Decisions

    Part 4. Role of Published Guidelines and Literature in Treatment Decisions

    Dr. Harris reviews the role of NCCN guidelines and clinical trial data in making treatment decisions for patients with BC.

    • 2 min
    Part 3. Case Continues

    Part 3. Case Continues

    Dr. Harris discusses the patient’s participation in a phase II trial of iniparib and the MOA of PARP inhibitors.

    • 3 min
    Part 2. Selecting From Available Treatment Options

    Part 2. Selecting From Available Treatment Options

    Dr. Harris describes recommendations for staging patients with early disease and recommendations individualizing these according to patient and disease characteristics.

    • 2 min
    Part 1. Case Presentation

    Part 1. Case Presentation

    Dr. Harris discusses the diagnosis, staging, and initial treatment of triple-negative breast cancer in a 39-year-old woman with a family history of breast cancer (BC).

    • 6 min

Top Podcasts In Science

More by Projects In Knowledge, Inc